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 Objetivo: A literatura publicada sugere que as propriedades biomecânicas da 
córnea, nomeadamente a espessura central da córnea (ECC) e a histerese corneana (HC), 
influenciam a medição da pressão intraocular (PIO). Este estudo teve como objetivo 
investigar a associação entre a ECC e a HC e o desenvolvimento de glaucoma.  
 Métodos: Revisão da literatura e meta-análise. Foram incluídos estudos 
observacionais, publicados entre 2006 e 2016, que integrassem um grupo-controlo e um 
grupo de pacientes com glaucoma em que estes dois grupos apresentassem, igualmente, 
a ECC e a HC como outcomes. Dezanove estudos foram considerados elegíveis e a 
diferença média (MD) daqueles parâmetros nos dois grupos foi utilizada para análise 
estatística.  
 Resultados: Estudaram-se um total de 1213 olhos com glaucoma e 1055 olhos 
saudáveis. A análise quantitativa revelou que a HC é significativamente mais baixa no 
grupo de doentes com glaucoma quando comparada com o grupo-controlo (𝑀𝐷 = -1.54 
µm, intervalo de confiança de 95% [-1.68, -1.41], P <0.00001). A ECC foi, também, 
significativamente mais baixa no grupo glaucoma quando comparada com os indivíduos 
saudáveis (𝑀𝐷  = -8.49 µm, intervalo de confiança de 95% [-11.36, -5.62], P <0.001).  
 Conclusão: Os pacientes com glaucoma parecem possuir propriedades corneanas 
diferentes das que apresentam os indivíduos saudáveis. Os nossos resultados enfatizam a 
importância das propriedades biomecânicas da córnea na interpretação da PIO e devem 
contribuir para novos estudos sobre a influência da HC e da ECC no rastreio e diagnóstico 
do glaucoma.   
 












Purpose: There is evidence suggesting that corneal biomechanical properties 
influence intraocular pressure (IOP) measurement, namely corneal central thickness 
(CCT) and corneal hysteresis (CH). This study aimed to investigate the association 
between CH and CCT with glaucoma development. 
Methods: Review of the literature and meta-analysis of observational studies 
(2006-2016) including both adult glaucoma patients and a control group, reporting CCT 
and CH as outcomes. Nineteen studies were considered eligible and the mean difference 
(MD) between groups (patient - control) of both variables was used for statistical 
analyses.  
Results: A total of 1213 glaucoma and 1055 healthy eyes were studied. 
Quantitative analysis suggested that CH was significantly lower in the glaucoma group 
compared to the control group (MD = -1.54 µm, 95% CI [-1.68, -1.41], P < 0.00001). The 
CCT was also significantly lower in the glaucoma group compared to healthy controls 
(MD = -8.49 µm, 95% CI [-11.36, -5.62], P < 0.001).   
 Conclusion: Glaucoma patients seem to have different corneal properties than 
healthy controls. Our results emphasize the importance of corneal biomechanical 
properties in IOP interpretation, and should trigger further studies on the influence of CH 
and CCT in glaucoma screening and diagnosis. 
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Glaucoma is the leading cause of irreversible blindness worldwide [1, 2]. This 
disease consists in a chronic and progressive optic neuropathy [1, 3] characterised by loss 
of retinal ganglion cells [3], which leads to visual field deterioration [1, 3, 4]. Moreover, 
glaucoma is associated with vehicle accidents, restricted mobility and falls, thus, affecting 
quality of life [1]. An important risk factor in glaucoma is intraocular pressure (IOP), and 
its decrease is the mainstay of treatment [3].  
Measurement of IOP has been a matter of debate for years. In 1950, Goldmann 
introduced a way of measuring IOP that is currently the gold standard - applanation 
tonometry [3–5]. However, this device is related to the elasticity of the cornea, which 
means that it is dependent on its thickness and hysteresis [4]. Goldmann assumed that the 
average central corneal thickness (CCT) would be approximately 500 µm [4–7], meaning 
that excessively thin or thick corneas would generate underestimations or overestimations 
of the IOP, respectively [4, 7, 8]. With the advent of more sophisticated devices capable 
of measuring CCT, it became clear that it is much more variable than Goldmann predicted 
[5–7]. More recently, some studies like the Ocular Hypertension Treatment Study 
(OHTS) stated CCT as an important confounder of Goldmann applanation tonometer 
(GAT) measurements [5, 6, 8]. Beyond this, factors like astigmatism, the examiner’s 
competence, direction of gaze, tear thickness, corneal hydration, connective tissue 
composition, bioelasticity, corneal curvature and other corneal biomechanical properties 
are also important sources of error in GAT [2–4, 8]. Currently, there is not yet an accepted 
formula to correct IOP [4, 6, 7]. 
The Ocular Response Analyzer (ORA) was introduced in 2005, classified as a 
non-contact tonometer [2, 3, 5, 9]. This tonometer allows the measurement and evaluation 
of corneal biomechanical properties, namely the corneal hysteresis (CH), corneal 
resistance factor (CRF), corneal compensated intraocular pressure (IOPcc) [3, 5] and also 
CCT and Goldmann correlated intraocular pressure (IOPg) [3, 5]. Briefly, the ORA 
produces a rapid air pulse that deforms the cornea curvature [2, 3, 5, 9] and records the 
corneal deformation [2, 9]. When the cornea is moving inwards, it reaches a first 
applanation state (P1) [2, 3, 9]. After a slightly concave state [2, 3, 9], the air pulse 
pressure decreases and the cornea moves outwardly, passing through a second 
applanation state (P2) [2, 3, 9]. The average of P1 and P2 is IOPg - analogous to the IOP 
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measured by GAT [2, 5, 9] - being the difference between these two values the value of 
CH [2, 3, 5].  
The OHTS revealed that CCT is an important and independent risk factor for the 
development of glaucoma [4–6, 10]. These results were validated in the European 
Glaucoma Prevention Study (EGPS) [4, 5]. In fact, it was found a two-fold increased risk 
for the progression to glaucoma over 5 years for each 40 mm thinning of the central cornea 
[4], meaning that a patient with a thinner cornea has more risk of glaucoma progression 
[4, 6]. However, this was not true in other studies. For instance, in the Early Manifest 
Glaucoma Trial (EMGT), with 5 years of follow up, CCT was not a significant predictive 
factor for glaucoma progression [4]. The value of CCT as significant predictive factor for 
the progression of glaucoma was only true for those patients with higher baseline IOP 
and not for those with lower baseline IOP after 11 years of follow up [4]. Furthermore, 
other studies, such as the Barbados Eye Study, the ones by Chauhan et al and Congdon et 
al, did not find any association between CCT and glaucoma [2, 4].  
Interestingly, Nathan Congdon and colleagues showed that CH is associated with 
glaucoma progression risk [2, 5, 9]. This evidence suggests that low CH is associated with 
glaucomatous visual field damage and optic nerve defects [2, 9]. In fact, CH may be more 
strongly associated with glaucoma diagnosis, risk of progression and effectiveness of 
glaucoma treatments than CCT itself [2, 9]. 
All in all, the biological link between the biomechanical properties of the eye and 
glaucoma development and progression [4–6] remains to be understood.   
Our review aimed to investigate the association between CH and CCT with 













 Our study is the first review of the literature and meta-analysis collecting CCT 
and CH data from adults with glaucoma and heathy controls in order to discuss 
differences in those two outcomes for both groups. This study started on July 2016. 
 
Eligibility criteria 
In this study, we only considered observational studies including adult patients 
(with a diagnosis of open angle glaucoma) and a control group reporting CCT and CH as 
outcomes.  
Other studies with any other ophthalmologic diagnosis that could affect IOP, 
studies not written in English, with an interventional design, with a non-healthy control 
group, paediatric patients and volunteers (age < 18 years) and which did not provide 
outcome values for each group separately, were excluded. 
We used this selective criteria to obtain a homogenous glaucoma and glaucoma 
related population with a healthy control group. We excluded any other diagnosis as a 
cause of the IOP and all interventional studies in order to reduce the possible bias 
associated with a heterogeneous group of diagnosis and the possible bias of procedures 
and medications performed during the studies.  
 
Information sources and Search 
MEDLINE was used as an information source and the search terms used were 
“hysteresis”, “glaucoma” and “corneal thickness”, from 2006 throughout July-2016. 
Since CH and CCT were our primary outcomes, we used “glaucoma”, “hysteresis” and 
“corneal thickness” as search terms in order to get access to a non-restrictive group of 











A total of 124 articles were found with this search criteria. The abstract from each 
article was used for screening, one of them was found to be duplicated. After screening, 
we found n = 45 studies, from which 2 were written in French, 2 written in German, 1 
was written in Czech, 3 included paediatric populations, 1 had no outcome information, 
2 studies had a case group including more than just glaucoma diagnosis, 2 provided the 
data from control and case groups together, 6 had a non-healthy control group and 7 were 
interventional studies.  
For comparative and quantitative purposes, 19 studies, from 2008 throughout 
2016, were considered for analysis. This information is presented in Figure 1, according 
to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines [11]. 
 
Data collection process and statistical analysis 
The selected full texts were collected and assessed for demographic data and 
reported outcomes. For the statistical analysis, we used the mean difference (MD) 





 From a total of 124 studies screened, only 19 of them complied with our eligibility 
criteria, as shown in Figure 1. Table 1 and Figures 2-3 summarize the mean and standard 
deviation (SD) of both CH and CCT for the control and case groups of each study.  
 
Synthesis of results 
 A total of 1213 glaucoma eyes, arising from 1159 glaucoma patients and 1055 
healthy eyes from 1021 healthy subjects, were considered in our study. Table 1 shows the 
baseline characteristics of these participants and their eye-related parameters.  
A quantitative analysis showed us that CH was significantly lower in the glaucoma 
group when compared to the control group (MD = -1.54 µm, 95% CI [-1.68, -1.41], P < 
0.00001) as shown in Figure 2. As we can observe in Figure 3, CCT was also significantly 
lower in the glaucoma group when compared to healthy controls (MD = -8.49 µm, 95% 




Summary of evidence, limitations and conclusions 
 The latest evidence is still unclear regarding the true value of CCT as a risk factor 
for glaucoma. While some studies stand up for CCT as an important risk factor for the 
development of glaucoma [4–6, 10], others like EMGT, Barbados Eye Study, Chauhan 
and Congdon, did not find such a simple and linear relationship between those two 
parameters [2, 4]. According to our study, there is a significantly lower CCT value among 
glaucoma patients (mean difference 8.49 µm, range [-11.36, -5.62], 95% CI; P = 0.0005) 
compared to the control group. However, it is hard to draw simple conclusions about the 
meaning of this difference for the two groups, since it is different to applanate a thinner 
or a thicker surface, becoming easier or harder to applanate the cornea, respectively [9]. 
So, in other words, CCT may result in a confounding factor for IOP measured by GAT 
rather than an independent risk factor for the disease.  
 The ORA device give us several biomechanical properties that are assumed to be 
less influenced by CCT when compared to GAT, namely CH, which is a biomechanical 
property related to the viscoelasticity of the cornea. According to our results, there is a 
significantly lower CH among glaucoma patients, compared to healthy controls (mean 
difference 1.54 mmHg, range [-1.68, -1.41], 95% CI; P < 0.00001), which is in agreement 
with previous results from other studies [2, 9]. Since ORA is a non-contact tonometer [2, 
3, 5, 9], parameters measured by this device may be more reliable than GAT [2, 3].  
 From these study results, a relevant question that rises is about the applicability of 
CH as an instrument in clinical practice and its reliability. Standard CCT measurements 
have been widely used and may help interpret IOP findings, but up to this day it remains 
undetermined whether this variable per se is useful for assessing a patient’s risk factor on 
developing the disease. In this sense, by providing further information about the corneal 
biomechanics, CH may be different. However, there is still not a consolidated evidence 
that allow us to replace the use of CCT for other marker such as CH, in the management 
of glaucoma patients. The fact that CH is not theoretically influenced by CCT [3, 5, 8, 9], 
which shows a large variability in the overall population [5–7], is very important, so it 
can become a valuable tool, for example, on the assessment of the stratification risk for 
glaucoma patients or even for prognosis. Yet, ORA is an instrument that is not commonly 




 The results of our study show a strong evidence on the subject. Furthermore, it 
should be pointed out that this is the first study review of the literature and meta-analysis 
about this topic involving corneal hysteresis in glaucoma. However, we recognize that 
our study has some limitations. We highlighted the fact that we include several glaucoma 
diagnosis [POAG, normal tension glaucoma (NTG), pre-perimetric POAG, 
pseudoexfoliative glaucoma (PEXG) and exfoliative glaucoma (EXG)], which can also 
bias the results, once the different physiopathology of each type of glaucoma may have a 
different impact on the cornea. Additionally, our study only considered articles from 2008 
through 2016, based on a strict criteria. Furthermore, the ORA device was only introduced 
in 2005. So, these two factors resulted in a relatively short period under review in our 
study. Finally, we also recognise some other limitations, namely, the fact that it is not a 
systematic review, that it has not a risk of bias evaluation and that we have only included 
observational studies with the purpose to eliminate the risk of bias from interventions in 
the groups.   
 Concluding, our study reveals a significant difference on CH and CCT between 
glaucoma patients and healthy controls. These results show that maybe the true 
assessment is beyond CCT measurement alone. So, it is important to keep searching for 
new and more sophisticated tools to measure corneal properties, as CH, to deepen our 
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Full-text articles assessed for 
eligibility  
(n = 45) 
Records screened (n = 123) 
Records after duplicates removed 
(n = 123) 
Studies included in qualitative 
synthesis (n =19) 
Records identified through 
database searching (n = 124) 
Additional records identified 
through other sources (n = 0) 
Articles excluded, with reasons (n = 26) 
Written in French (n = 2) 
Written in Czech (n = 1) 
Written in German (n = 2) 
With an interventional design (n = 7) 
Without a healthy control group (n = 6) 
Paediatric population (n = 3) 
Lack of outcomes information (n = 1) 
Outcome values from control and case 
group together (n = 2) 
Control group with multiple diagnosis   
(n = 2) 
 
Records excluded (n = 78) 
Studies included in quantitative 
synthesis (meta-analysis (n =19) 


















Figure 2: Corneal Hysteresis - Forest plot 
CI = confidence interval. SD = Standard deviation.  
Figure 3: Central Corneal Thickness - Forest plot 









No. of eyes 
CH CCT 
Mean ± SD 
(mmHg) 
Mean ± SD 
(µm) 
Kurysheva, 2016 
Glaucoma 32 32 10,1 ± 1,6 548,1 ± 31,3 
Control 30 30 11,2 ± 1,7 549,3 ± 30,8 
Pillunat, 2016 
Glaucoma 48 48 8,54 ± 1,86 530,6 ± 38,4 
Control 44 44 10,49 ± 1,67 556,2 ± 37 
SHIN, 2015 
Glaucoma 97 97 9,9 ± 1,66 548,3 ± 34,82 
Control 89 89 10,59 ± 1,71 558,77 ± 31,19 
Beyazyıldız, 2014 
Glaucoma 66 66 9,1 ± 1,9 550,4 ± 36,3 
Control 50 50 9,6 ± 1,7 537,3 ± 38,5 
Yazgan, 2014 
Glaucoma 30 30 6,8 ± 1,7 509 ± 36 
Control 45 45 10,3 ± 1,5 546,3 ± 28 
Costin, 2014 
Glaucoma 13 13 9,02 ± 1,52 546,7 ± 35 
Control 15 15 10,26 ± 1,3 546,1 ± 35,5 
Insull, 2010 
Glaucoma 38 38 8,8 ± 1,5212 532 ± 33,466 
Control 62 62 9,6 ± 1,4963 550 ± 35,4397 
Sullivan-Mee, 2012 
Glaucoma 116 116 7,76 ± 1,6 541 ± 36 
Control 67 67 9,54 ± 1,6 552 ± 35 
Kaushik, 2012 
Glaucoma 36 36 7,9 ± 2,8 523,5 ± 35,5 
Control 71 71 9,5 ± 1,4 530,7 ± 33,4 
Detry-Morel, 2012 
Glaucoma 30 30 9,2 ± 1,1 544 ± 37 
Control 25 25 10,8 ± 1,6 554 ± 19 
Morita, 2012 
Glaucoma 83 83 9,2 ± 1,3 535,4 ± 24,9 
Control 83 83 10,8 ± 1,3 541,4 ± 26,8 
Cankaya, 2011 
Glaucoma 78 78 6,9 ± 2,1 537,9 ± 35,2 
Control 102 102 9,4 ± 1,4 539,8 ± 25,9 
Grise-Dulac, 2012 
Glaucoma 38 75 10,03 ± 2,31 551,5 ± 38,9 
Control 22 44 11,05 ± 1,53 550,7 ± 29,3 
Detry-Morel, 2011 
Glaucoma 108 108 9,2 ± 1,6 536 ± 61 
Control 24 24 10,8 ± 1,8 550 ± 36 
Xu, 2011 
Glaucoma 60 60 9,61 ± 1,56 541,4 ± 37,46 
Control 60 60 10,4 ± 1,62 541,75 ± 26,07 
Abitbol, 2010 
Glaucoma 58 58 8,77 ± 1,4 535,34 ± 42,7 
Control 75 75 10,46 ± 1,6 560,2 ± 36,3 
Villas-Bôas, 2009 
Glaucoma 21 38 8.90 ± 2.1 514.80 ± 41.3 
Control 12 24 10.20 ± 1.6 529.00 ± 45.4 
Mangouritsas, 2009 
Glaucoma 108 108 8,95 ± 1,27 526,77 ± 35,73 
Control 74 74 10,97 ± 1,59 537,84 ± 41,93 
Sullivan-Mee, 2008 
Glaucoma 99 99 8,1 ± 1,5 541 ± 41 
Control 71 71 9,7 ± 1,5 546 ± 33 
 
Table 1: Baseline characteristics 
 
CCT = central corneal thickness. CH = corneal hysteresis. No = number. 
SD = standard deviation  
 
